Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2023-02-02 00:00:00 ET · period of report 2023-01-31 · accession 0001209191-23-006204 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-02 | 2023-01-31 | VRTX | SACHS BRUCE I | Dir | M - OptEx | $72.14 | +1,200 | 42.4K | +3% | +$86.6K |
| D | 2023-02-02 | 2023-01-31 | VRTX | SACHS BRUCE I | Dir | S - Sale+OE | $325.01 | -1,200 | 41.2K | -3% | -$390.0K |
| D | 2023-02-02 | 2023-01-31 | VRTX | SACHS BRUCE I | Dir | M - OptEx | $0.00 | -1,200 | 21.3K | -5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-31 | M | A | 1,200 | $72.14 | 42,410 | D | — | — | |
| 2 | Common | Common Stock | 2023-01-31 | S | D | 1,200 | $325.01 | 41,210 | D | — | — | (F2) Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F3) Open market sales reported on this line occurred at a weighted average price of $325.01 (range $325.00 to $325.01). |
| 3 | Derivative | Stock Option (Right to Buy) | 2023-01-31 | M | D | 1,200 | $0.00 | 21,300 | D | $72.14 · — to 2024-05-31 | 1,200 Common Stock | (F4) Fully vested. |